Lung Cancer

Oncology·MeSH: Lung Neoplasms

Prevalence

75.0 / 100K

Incidence

47.0 / 100K/yr

469 drugs in development·145 companies·81 clinical trials

Drug Pipeline by Phase

Approved(23)

Drug	Company
Alimta®	ELI LILLY & Co (LLY)
Aybintio (SB8)	Organon & Co. (OGN)
cosela	G1 Therapeutics, Inc. (GTHX)
cypath lung	bioAffinity Technologies Inc. (BIAF)
Cyramza	ELI LILLY & Co (LLY)
docetaxel	Amneal Pharmaceuticals, Inc. (AMRX)
emrelis	AbbVie Inc. (ABBV)
gavreto	RIGEL PHARMACEUTICALS INC (RIGL)
genestrat ddpcr	Biodesix Inc. (BDSX)
genestrat ngs	Biodesix Inc. (BDSX)
ibtrozi	Nuvation Bio Inc. (NUVB)
Imdelltra	Royalty Pharma plc (RPRX)
krazati	BRISTOL MYERS SQUIBB CO (BMY)
lorbrena	PFIZER INC (PFE)
opdivo qvantig	BRISTOL MYERS SQUIBB CO (BMY)
paclitaxel	Mylan II B.V. (MYL)
pemetrexed	DR REDDYS LABORATORIES LTD (RDY)
pemfexy	EAGLE PHARMACEUTICALS, INC. (EGRX)
portrazza	ELI LILLY & Co (LLY)
veristrat	Biodesix Inc. (BDSX)
vizimpro	PFIZER INC (PFE)
Zenocutuzumab (Zeno) / BIZENGRI® (zenocutuzumab-zbco)	Merus N.V. (MRUS)
Zepzelca	Jazz Pharmaceuticals plc (JAZZ)

Phase 3(150)

Drug	Company
[177Lu]Lu-DOTA-TATE	Novartis AG (NVS)
abenacianine	Ventyx Biosciences, Inc. (VTYX)
abp 234	AMGEN INC (AMGN)
acasunlimab	Genmab A/S (GMAB)
ak112	Summit Therapeutics Inc. (SMMT)
AK112 Injection	Summit Therapeutics Inc. (SMMT)
Alectinib	Nuvalent, Inc. (NUVL)
amivantamab	GH Research PLC (GHRS)
amivantamab	GH Research PLC (GHRS)
amivantamab	GH Research PLC (GHRS)
Amivantamab	Merus N.V. (MRUS)
Amrubicin	Merus N.V. (MRUS)
Amrubicin	Merck & Co., Inc. (MRK)
aumolertinib	EQRx, Inc. (EQRX)
autologous	ASTRAZENECA PLC (AZN)
avutometinib	Verastem, Inc. (VSTM)
azacytidine	Merus N.V. (MRUS)
azd0171	ASTRAZENECA PLC (AZN)
azd0240	ASTRAZENECA PLC (AZN)
AZD2936	ASTRAZENECA PLC (AZN)
azd9291	ASTRAZENECA PLC (AZN)
bgb-15025	BeOne Medicines Ltd. (ONC)
BGB-15025	BeOne Medicines Ltd. (ONC)
bgb-a445	BeOne Medicines Ltd. (ONC)
BGB-A445	BeOne Medicines Ltd. (ONC)
Calderasib	Merck & Co., Inc. (MRK)
CAN-2409	Candel Therapeutics, Inc. (CADL)
canakinumab	Novartis AG (NVS)
Ceralasertib	ASTRAZENECA PLC (AZN)
cetuximab	Novartis AG (NVS)
Cetuximab	ENANTA PHARMACEUTICALS INC (ENTA)
cobolimab	ANAPTYSBIO, INC (ANAB)
Crizotinib	Nuvation Bio Inc. (NUVB)
custirsen	ACHIEVE LIFE SCIENCES, INC. (ACHV)
daraxonrasib	REVOLUTION MEDICINES, INC. (RVMD)
Dato-DXd	ASTRAZENECA PLC (AZN)
datopotamab deruxtecan	ASTRAZENECA PLC (AZN)
Datopotamab Deruxtecan	Merus N.V. (MRUS)
Divarasib	ENANTA PHARMACEUTICALS INC (ENTA)
Domvanalimab	ASTRAZENECA PLC (AZN)
Dostarlimab	ANAPTYSBIO, INC (ANAB)
Dostarlimab and TSR-022	ANAPTYSBIO, INC (ANAB)
drug	ImmunityBio, Inc. (IBRX)
eftilagimod alfa	IMMUTEP Ltd (PRRUF)
eftilagimod alfa	Immutep Limited (IMMP)
Eftilagimod Alfa	Immutep Limited (IMMP)
egfr-tki inhibitor based on investigator's choice	ArriVent BioPharma, Inc. (AVBP)
elironrasib	REVOLUTION MEDICINES, INC. (RVMD)
Entrectinib	Merus N.V. (MRUS)
Erlotinib	ENANTA PHARMACEUTICALS INC (ENTA)
Erlotinib	Merus N.V. (MRUS)
erlotinib 150/100 mg	ASTRAZENECA PLC (AZN)
Etoposide	BioNTech SE (BNTX)
ETOPOSIDE - Study	Design Therapeutics, Inc. (DSGN)
ETOPOSIDE - Usual	Design Therapeutics, Inc. (DSGN)
Etoposide Injection	ASTRAZENECA PLC (AZN)
firmonertinib	ArriVent BioPharma, Inc. (AVBP)
Firmonertinib	ADMA BIOLOGICS, INC. (ADMA)
Firmonertinib	Merus N.V. (MRUS)
Firmonertinib	Relay Therapeutics, Inc. (RLAY)
FOLFIRI+cetuximab	IGM Biosciences, Inc. (IGMS)
FOLFOX6/FOLFOX7	IGM Biosciences, Inc. (IGMS)
furmonertinib	ArriVent BioPharma, Inc. (AVBP)
gotistobart	Onconetix, Inc. (ONCO)
Gotistobart	BioNTech SE (BNTX)
HER3-DXd	Merck & Co., Inc. (MRK)
I-DXd	Merck & Co., Inc. (MRK)
Immune Globulin Subcutaneous, 20% Solution	ENANTA PHARMACEUTICALS INC (ENTA)
Inavolisib	ENANTA PHARMACEUTICALS INC (ENTA)
Intismeran autogene	Merck & Co., Inc. (MRK)
ivonescimab	Summit Therapeutics Inc. (SMMT)
ivonescimab + ligufalimab	Summit Therapeutics Inc. (SMMT)
Ivonescimab Injection	Summit Therapeutics Inc. (SMMT)
JDQ443	Novartis AG (NVS)
lazertinib	GH Research PLC (GHRS)
Lazertinib	Merus N.V. (MRUS)
lbl-007	BeOne Medicines Ltd. (ONC)
LBL-007	BeOne Medicines Ltd. (ONC)
Lenvatinib	Merck & Co., Inc. (MRK)
Lurbinectedin	Merus N.V. (MRUS)
Lurbinectedin	Merck & Co., Inc. (MRK)
Lurbinectedin	Crinetics Pharmaceuticals, Inc. (CRNX)
MEDI5752	ASTRAZENECA PLC (AZN)
Nelistotug	iTeos Therapeutics, Inc. (ITOS)
nvl-655	Nuvalent, Inc. (NUVL)
ociperlimab	BeOne Medicines Ltd. (ONC)
olafertinib	Checkpoint Therapeutics, Inc. (CKPT)
olaparib pill	GH Research PLC (GHRS)
osimertinib	Incyte Corp. (INCY)
Osimertinib	BRISTOL MYERS SQUIBB CO (BMY)
Osimertinib	Crinetics Pharmaceuticals, Inc. (CRNX)
Osimertinib + Savolitinib	ASTRAZENECA PLC (AZN)
Panitumumab	IGM Biosciences, Inc. (IGMS)
part a - azd9291 in combination with continuous selumetinib	ASTRAZENECA PLC (AZN)
part a - azd9291 in combination with medi4736	ASTRAZENECA PLC (AZN)
part b - azd9291 in combination with medi4736	ASTRAZENECA PLC (AZN)
part b - azd9291 in combination with selumetinib	ASTRAZENECA PLC (AZN)
pemetrexed	BeOne Medicines Ltd. (ONC)
pemetrexed	GILEAD SCIENCES, INC. (GILD)
pemetrexed	Incyte Corp. (INCY)
Pemetrexed	BRISTOL MYERS SQUIBB CO (BMY)
Pemetrexed	ENANTA PHARMACEUTICALS INC (ENTA)
Pemetrexed	Merck & Co., Inc. (MRK)
Pemetrexed Disodium	Merus N.V. (MRUS)
platinum-based chemotherapy	ArriVent BioPharma, Inc. (AVBP)
Plinabulin	BeyondSpring Inc. (BYSI)
Pralsetinib	Merus N.V. (MRUS)
Pumitamig	BRISTOL MYERS SQUIBB CO (BMY)
radiation	ASTRAZENECA PLC (AZN)
Ramucirumab	ASTRAZENECA PLC (AZN)
regn2810/chemo/ipi	REGENERON PHARMACEUTICALS, INC. (REGN)
Rescue Medication	Merck & Co., Inc. (MRK)
Rescue Medications	Merck & Co., Inc. (MRK)
retifanlimab	Incyte Corp. (INCY)
Rilvegostomig	ASTRAZENECA PLC (AZN)
rmc-4630	REVOLUTION MEDICINES, INC. (RVMD)
rmc-6236	REVOLUTION MEDICINES, INC. (RVMD)
rmc-6291	REVOLUTION MEDICINES, INC. (RVMD)
rmc-9805	REVOLUTION MEDICINES, INC. (RVMD)
Rucaparib	Merck & Co., Inc. (MRK)
sacituzumab govitecan	GILEAD SCIENCES, INC. (GILD)
Sacituzumab tirumotecan	Merck & Co., Inc. (MRK)
Sacituzumab tirumotecan	Merus N.V. (MRUS)
savolitinib	HUTCHMED (China) Limited (HCM)
savolitinib + osimertinib	HUTCHMED (China) Limited (HCM)
sotorasib	REVOLUTION MEDICINES, INC. (RVMD)
Supportive care measures	Merck & Co., Inc. (MRK)
t-dxd	ASTRAZENECA PLC (AZN)
tak-788	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-788	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Taletrectinib	Nuvation Bio Inc. (NUVB)
Telisotuzumab vedotin	AbbVie Inc. (ABBV)
Topotecan	Merck & Co., Inc. (MRK)
Topotecan	Crinetics Pharmaceuticals, Inc. (CRNX)
trametinib	Deciphera Pharmaceuticals, Inc. (DCPH)
Trametinib	Novartis AG (NVS)
tremelimumab	GH Research PLC (GHRS)
Tremelimumab	ASTRAZENECA PLC (AZN)
trilaciclib	G1 Therapeutics, Inc. (GTHX)
tsr-042	TESARO, Inc. (TSRO)
Tyrosine kinase Inhibitors	ENANTA PHARMACEUTICALS INC (ENTA)
uft	ASTRAZENECA PLC (AZN)
V940	Merck & Co., Inc. (MRK)
vinorelbine	ASTRAZENECA PLC (AZN)
Vinorelbine Tartrate	ENANTA PHARMACEUTICALS INC (ENTA)
Volrustomig	ASTRAZENECA PLC (AZN)
Zipalertinib (CLN-081/TAS6417)	Cullinan Therapeutics, Inc. (CGEM)
zl-1310	Zai Lab Ltd (ZLAB)
ZL-1310	Merus N.V. (MRUS)
Zongertinib	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 2(101)

Drug	Company
[177Lu]Lu-DOTATATE	Novartis AG (NVS)
AB-106	Nuvation Bio Inc. (NUVB)
ABBV-706	AbbVie Inc. (ABBV)
ABT-869	AbbVie Inc. (ABBV)
ABT-869 .25 mg/kg	AbbVie Inc. (ABBV)
ABT-869 0.10 mg/kg	AbbVie Inc. (ABBV)
Alectinib	Merus N.V. (MRUS)
alisertib	PUMA BIOTECHNOLOGY, INC. (PBYI)
alk202	SAB BIOTHERAPEUTICS, INC. (SABS)
am0010	ARMO BIOSCIENCES, INC. (ARMO)
amivantamab	ASTRAZENECA PLC (AZN)
anlotinib	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
anti-pd-1/l1	HUTCHMED (China) Limited (HCM)
AZD1775	ADMA BIOLOGICS, INC. (ADMA)
AZD1775	Relay Therapeutics, Inc. (RLAY)
azd2811	ASTRAZENECA PLC (AZN)
BDTX-1535	Black Diamond Therapeutics, Inc. (BDTX)
bnt116	REGENERON PHARMACEUTICALS, INC. (REGN)
BNT327 Dose Level 1	BioNTech SE (BNTX)
BNT327 Dose Level 2	BioNTech SE (BNTX)
Budigalimab	AbbVie Inc. (ABBV)
capmatinib	Novartis AG (NVS)
capmatinib	Novartis AG (NVS)
Cemiplimab	Merus N.V. (MRUS)
Cemiplimab 350 mg IV	Merus N.V. (MRUS)
Cobimetinib	Merus N.V. (MRUS)
ct053ptsa	SUNSHINE BIOPHARMA INC. (SBFM)
cylembio	IO Biotech, Inc. (IOBT)
Divarasib	Merus N.V. (MRUS)
domvanalimab	GILEAD SCIENCES, INC. (GILD)
env 105	Kairos Pharma, LTD. (KAPA)
EOS-448	iTeos Therapeutics, Inc. (ITOS)
Etoposide	AbbVie Inc. (ABBV)
Etoposide	Merck & Co., Inc. (MRK)
etrumadenant	Arcus Biosciences, Inc. (RCUS)
etrumadenant	GILEAD SCIENCES, INC. (GILD)
Etrumadenant	Arcus Biosciences, Inc. (RCUS)
fianlimab	REGENERON PHARMACEUTICALS, INC. (REGN)
FOLFOX	ENANTA PHARMACEUTICALS INC (ENTA)
fs118	F-star Therapeutics, Inc. (FSTX)
Ifinatamab Deruxtecan	Merus N.V. (MRUS)
Immune Checkpoint Inhibitors	ENANTA PHARMACEUTICALS INC (ENTA)
incb086550	Incyte Corp. (INCY)
inupadenant	iTeos Therapeutics, Inc. (ITOS)
inupadenant (EOS-850)	iTeos Therapeutics, Inc. (ITOS)
ivonescimab	GH Research PLC (GHRS)
Livmoniplimab	AbbVie Inc. (ABBV)
LN-145	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Lorigerlimab	MACROGENICS INC (MGNX)
Lurbinectedin	Jazz Pharmaceuticals plc (JAZZ)
Lurbinectedin	AbbVie Inc. (ABBV)
Luveltamab tazevibulin	SUTRO BIOPHARMA, INC. (STRO)
MGC018	MACROGENICS INC (MGNX)
N-803	CG Oncology, Inc. (CGON)
N-803 + Avelumab	ImmunityBio, Inc. (IBRX)
N-803 + Avelumab + PD-L1 t-haNK	ImmunityBio, Inc. (IBRX)
NALIRIFOX	Merus N.V. (MRUS)
Olaparib	Merus N.V. (MRUS)
Oleclumab	ASTRAZENECA PLC (AZN)
olvimulogene nanivacirepvec	GENELUX Corp (GNLX)
osimertinib	SUNSHINE BIOPHARMA INC. (SBFM)
Osimertinib alone	Crinetics Pharmaceuticals, Inc. (CRNX)
part a - azd9291 in combination with azd6094	ASTRAZENECA PLC (AZN)
part b - azd9291 in combination with azd6094	ASTRAZENECA PLC (AZN)
part c - azd9291 in combination with azd6094	ASTRAZENECA PLC (AZN)
part d - azd9291 in combination with azd6094	ASTRAZENECA PLC (AZN)
Patritumab Deruxtecan	Merus N.V. (MRUS)
Pemetrexed	Arcus Biosciences, Inc. (RCUS)
Pemetrexed	Merus N.V. (MRUS)
Pemetrexed	iTeos Therapeutics, Inc. (ITOS)
Pemetrexed Disodium for Injection	Merus N.V. (MRUS)
platinum doublet	REGENERON PHARMACEUTICALS, INC. (REGN)
platinum-based doublet	GILEAD SCIENCES, INC. (GILD)
poziotinib	Assertio Holdings, Inc. (ASRT)
quemliclustat	GILEAD SCIENCES, INC. (GILD)
REC-4539	RECURSION PHARMACEUTICALS, INC. (RXRX)
reqorsa	Genprex, Inc. (GNPX)
RP1	ENANTA PHARMACEUTICALS INC (ENTA)
rtx-224	Rubius Therapeutics, Inc. (RUBY)
rucosopasem manganese	Galera Therapeutics, Inc. (GRTX)
sacituzumab govitecan-hziy	GILEAD SCIENCES, INC. (GILD)
Sapanisertib (CB-228, formerly TAK-228)	Calithera Biosciences, Inc. (CALA)
sarilumab	REGENERON PHARMACEUTICALS, INC. (REGN)
SBRT	Merus N.V. (MRUS)
Serplulimab	Merus N.V. (MRUS)
stenoparib	Allarity Therapeutics, Inc. (ALLR)
tislelizumab	Novartis AG (NVS)
tislelizumab	Novartis AG (NVS)
Topotecan	BioNTech SE (BNTX)
trametinib	Novartis AG (NVS)
trc102	Tracon Pharmaceuticals, Inc. (TCON)
Tremelimumab	ADMA BIOLOGICS, INC. (ADMA)
tusamitamab ravtansine	Sanofi (SNY)
ubamatamab	REGENERON PHARMACEUTICALS, INC. (REGN)
V940	Merus N.V. (MRUS)
Vemurafenib	Merus N.V. (MRUS)
Vinorelbine	ENANTA PHARMACEUTICALS INC (ENTA)
vintafolide	ENDOCYTE INC (ECYT)
wsd0922-fu	SUNSHINE BIOPHARMA INC. (SBFM)
Zelenectide pevedotin	Merus N.V. (MRUS)
zelenectide pevedotin (formerly BT8009)	BICYCLE THERAPEUTICS PLC (BCYC)

Phase 1(102)

Drug	Company
[68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G.	UNITED THERAPEUTICS Corp (UTHR)
AB248	AMGEN INC (AMGN)
ABT-263	AbbVie Inc. (ABBV)
ADCT-601	ADC Therapeutics SA (ADCT)
alk-inhibitor or ret-inhibitor	BioNTech SE (BNTX)
ALT-803	ENANTA PHARMACEUTICALS INC (ENTA)
ALX2004	ALX ONCOLOGY HOLDINGS INC (ALXO)
anti-B7-H3 antibody conjugated to topoisomerase I inhibitor	BioNTech SE (BNTX)
anti-HER3 antibody conjugated to topoisomerase I inhibitor	BioNTech SE (BNTX)
anvumetostat	AMGEN INC (AMGN)
apg-1252	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
AUTO6NG	Autolus Therapeutics plc (AUTL)
autologous genetically modified t cells	Adaptimmune Therapeutics PLC (ADAP)
azacytidine	ENANTA PHARMACEUTICALS INC (ENTA)
AZD2936	Merus N.V. (MRUS)
azirkitug	AbbVie Inc. (ABBV)
BBO-10203	BridgeBio Oncology Therapeutics, Inc. (BBOT)
bbo-11818	BridgeBio Oncology Therapeutics, Inc. (BBOT)
BBO-11818	BridgeBio Pharma, Inc. (BBIO)
BBO-11818	Merus N.V. (MRUS)
BBO-11818	ENANTA PHARMACEUTICALS INC (ENTA)
BBO-8520	BridgeBio Oncology Therapeutics, Inc. (BBOT)
bg-60366	BeOne Medicines Ltd. (BEIGF)
bg-60366	BeOne Medicines Ltd. (ONC)
bispecific antibody for pd-l1	BioNTech SE (BNTX)
Bispecific antibody for PD-L1 and VEGF-A	BioNTech SE (BNTX)
BNT116	BioNTech SE (BNTX)
BNT316	BioNTech SE (BNTX)
BNT324	Merus N.V. (MRUS)
BNT327	Merus N.V. (MRUS)
C-TIL051	NEKTAR THERAPEUTICS (NKTR)
Cemiplimab	BioNTech SE (BNTX)
Cemiplimab	Merck & Co., Inc. (MRK)
cetuximab	BridgeBio Oncology Therapeutics, Inc. (BBOT)
Cetuximab	BridgeBio Pharma, Inc. (BBIO)
CFT8919	C4 Therapeutics, Inc. (CCCC)
CT-1119	Carisma Therapeutics Inc. (CARM)
Danvatirsen	Merus N.V. (MRUS)
Danvatirsen	ASTRAZENECA PLC (AZN)
deltacel	Kiromic Biopharma, Inc. (KRBP)
Digoxin	Merck & Co., Inc. (MRK)
ec1456	ENDOCYTE INC (ECYT)
elvn-002	Enliven Therapeutics, Inc. (ELVN)
enozertinib	Oric Pharmaceuticals, Inc. (ORIC)
Entinostat	Syndax Pharmaceuticals Inc (SNDX)
FOLFIRI	IGM Biosciences, Inc. (IGMS)
FOLFOX	BridgeBio Pharma, Inc. (BBIO)
FT836	FATE THERAPEUTICS INC (FATE)
GDC-1971	ENANTA PHARMACEUTICALS INC (ENTA)
GDC-6036	ENANTA PHARMACEUTICALS INC (ENTA)
gen-011	GENOCEA BIOSCIENCES, INC. (GNCA)
Gocatamig	Merus N.V. (MRUS)
H1299 Cell Lysates	CG Oncology, Inc. (CGON)
IDE161	IDEAYA Biosciences, Inc. (IDYA)
ide849	IDEAYA Biosciences, Inc. (IDYA)
IDE849 (SHR-4849)	IDEAYA Biosciences, Inc. (IDYA)
imgc936	ImmunoGen, Inc. (IMGN)
investigator's treatment of choice	Genprex, Inc. (GNPX)
JANX008	Janux Therapeutics, Inc. (JANX)
kin-2787	KINNATE BIOPHARMA INC. (KNTE)
ko-2806	Kura Oncology, Inc. (KURA)
LB2102	Legend Biotech Corp (LEGN)
ln-145	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
lymphocyte immune globulin	ENANTA PHARMACEUTICALS INC (ENTA)
MEDI5752	Merus N.V. (MRUS)
mfolfirinox	BridgeBio Oncology Therapeutics, Inc. (BBOT)
mFOLFOX6	BridgeBio Oncology Therapeutics, Inc. (BBOT)
Midazolam	Merck & Co., Inc. (MRK)
mobocertinib	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
mobocertinib	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
nalirifox	BridgeBio Oncology Therapeutics, Inc. (BBOT)
NALIRIFOX	BridgeBio Pharma, Inc. (BBIO)
NALIRIFOX	ENANTA PHARMACEUTICALS INC (ENTA)
neo-pv-01	Neon Therapeutics, Inc. (NTGN)
nt-112	ASTRAZENECA PLC (AZN)
NVL-520	Nuvalent, Inc. (NUVL)
nxp900	Nuvectis Pharma, Inc. (NVCT)
Oleclumab	Merus N.V. (MRUS)
osimertinib	Nuvectis Pharma, Inc. (NVCT)
osimertinib	BioNTech SE (BNTX)
Osimertinib	Jazz Pharmaceuticals plc (JAZZ)
part c - azd6094 monotherapy	ASTRAZENECA PLC (AZN)
Pemetrexed	BridgeBio Pharma, Inc. (BBIO)
Pemetrexed	ADMA BIOLOGICS, INC. (ADMA)
platinum chemotherapy	BridgeBio Oncology Therapeutics, Inc. (BBOT)
Platinum chemotherapy	BridgeBio Pharma, Inc. (BBIO)
pritumumab	Nascent Biotech Inc. (NBIO)
Pumitamig	Merus N.V. (MRUS)
quaratusugene ozeplasmid	Genprex, Inc. (GNPX)
ramucirumab	Genprex, Inc. (GNPX)
rmc-5127	REVOLUTION MEDICINES, INC. (RVMD)
Rucaparib	ENANTA PHARMACEUTICALS INC (ENTA)
S241656	IGM Biosciences, Inc. (IGMS)
sar408701	Sanofi (SNY)
Tarlatamab	AMGEN INC (AMGN)
tas3351	CG Oncology, Inc. (CGON)
TNG260	Tango Therapeutics, Inc. (TNGX)
xmt-2056	Mersana Therapeutics, Inc. (MRSN)
yl201	AMGEN INC (AMGN)
Zidesamtinib	Nuvalent, Inc. (NUVL)
zimberelimab	GILEAD SCIENCES, INC. (GILD)
zl-1310	AMGEN INC (AMGN)

Preclinical(27)

Drug	Company
a+lcguard	Advanced Biomed Inc. (ADVB)
adxs-503	OS Therapies Inc (OSTX)
adxs-503	OLD AYALA, INC (AYLA)
aktx-102	Akari Therapeutics Plc (AKTX)
ast-vac2	ASTERIAS BIOTHERAPEUTICS, INC. (AST)
ATNM-400	Actinium Pharmaceuticals, Inc. (ATNM)
BP1003	BIO-PATH HOLDINGS, INC. (BPTH)
chi3l1 bsabs	Ocean Biomedical, Inc. (OCEA)
chi3l1 mab	Ocean Biomedical, Inc. (OCEA)
CLD-400 (RTNova)	Calidi Biotherapeutics Inc. (CLDI)
cx-908	CytomX Therapeutics, Inc. (CTMX)
EO-1022	Elevation Oncology, Inc. (ELEV)
Fourth-Generation EGFR Inhibitor	Theseus Pharmaceuticals, Inc. (THRX)
fyarro + adagrasib	Whitehawk Therapeutics, Inc. (WHWK)
gtb-5550	GT Biopharma, Inc. (GTBP)
KRAS program	Cogent Biosciences, Inc. (COGT)
mink-215	MiNK Therapeutics, Inc. (INKT)
nu.q cancer	VOLITIONRX LTD (VNRX)
oncr-021	Oncorus, Inc. (ONCR)
oncr-788	Oncorus, Inc. (ONCR)
Pan-mutant BRAF degrader program (proprietary)	Nurix Therapeutics, Inc. (NRIX)
Pan-mutant BRAF program (mutant BRAF degraders)	Nurix Therapeutics, Inc. (NRIX)
pan-ras	AIxCrypto Holdings, Inc. (AIXC)
suba-itraconazole	Inhibitor Therapeutics, Inc. (INTI)
THE-349	Theseus Pharmaceuticals, Inc. (THRX)
til	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
ttx-sipdl1	Transcode Therapeutics, Inc. (RNAZ)

Unknown(3)

Drug	Company
ADXS-503	Ayala Pharmaceuticals, Inc. (ADXS)
non-SGLT2 inhibitors	ENANTA PHARMACEUTICALS INC (ENTA)
Systemic oncological treatment	Merus N.V. (MRUS)

Early Phase 1(1)

Drug	Company
VTP-600	Barinthus Biotherapeutics plc. (BRNS)

N/A(2)

Drug	Company
Yishen Qutong Granules	Merus N.V. (MRUS)
Yishen Qutong Simulant Granules	Merus N.V. (MRUS)

Phase 1/Phase 2(36)

Drug	Company
[177lu]lu-dota-tate	Novartis AG (NVS)
[68ga]ga-dota-tate	Novartis AG (NVS)
[68Ga]Ga-DOTA-TATE	Novartis AG (NVS)
ABV-1519	ABVC BIOPHARMA, INC. (ABVC)
BNT324	BioNTech SE (BNTX)
BNT326	BioNTech SE (BNTX)
BNT327	BioNTech SE (BNTX)
cetuximab	Novartis AG (NVS)
cetuximab	REVOLUTION MEDICINES, INC. (RVMD)
chemotherapy	Krystal Biotech, Inc. (KRYS)
Chemotherapy	Merus N.V. (MRUS)
dji136	NOVARTIS AG (NVSEF)
dji136	Novartis AG (NVS)
dzd6008	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Gocatamig	Merck & Co., Inc. (MRK)
hpn328	Harpoon Therapeutics, Inc. (HARP)
ide397	AMGEN INC (AMGN)
ifinatamab deruxtecan	Merck & Co., Inc. (MRK)
inlexisertib	Deciphera Pharmaceuticals, Inc. (DCPH)
jdq443	Novartis AG (NVS)
kb707	Krystal Biotech, Inc. (KRYS)
loxo-292	ELI LILLY & Co (LLY)
m1774	GH Research PLC (GHRS)
MCLA-129	Merus N.V. (MRUS)
Neladalkib	Nuvalent, Inc. (NUVL)
opnurasib	Novartis AG (NVS)
opnurasib	NOVARTIS AG (NVSEF)
osimertinib	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Osimertinib	Merus N.V. (MRUS)
pemetrexed	REVOLUTION MEDICINES, INC. (RVMD)
platinum-based chemotherapy	REGENERON PHARMACEUTICALS, INC. (REGN)
REC-617	RECURSION PHARMACEUTICALS, INC. (RXRX)
regn7075	REGENERON PHARMACEUTICALS, INC. (REGN)
TNG456	Tango Therapeutics, Inc. (TNGX)
tno155	Novartis AG (NVS)
tno155	Novartis AG (NVS)

Phase 2/Phase 3(10)

Drug	Company
CA-170	CURIS INC (CRIS)
eik1001	Eikon Therapeutics Inc. (EIKN)
iza-bren	BRISTOL MYERS SQUIBB CO (BMY)
osimertinib	AbbVie Inc. (ABBV)
Pemetrexed	AbbVie Inc. (ABBV)
Pemetrexed	BioNTech SE (BNTX)
screening platform	GH Research PLC (GHRS)
sitravatinib	Mirati Therapeutics, Inc. (MRTX)
surufatinib	HUTCHMED (China) Limited (HCM)
Telisotuzumab Adizutecan	AbbVie Inc. (ABBV)

Phase 4(14)

Drug	Company
5-FU	Merus N.V. (MRUS)
bms-986012	BRISTOL MYERS SQUIBB CO (BMY)
bms-986489	BRISTOL MYERS SQUIBB CO (BMY)
BMS-986504	BRISTOL MYERS SQUIBB CO (BMY)
BMS-986507	BRISTOL MYERS SQUIBB CO (BMY)
BMS-986525	BRISTOL MYERS SQUIBB CO (BMY)
canakinumab	Novartis AG (NVS)
Cetuximab	IGM Biosciences, Inc. (IGMS)
IBI363 + Chemotherapy	Merus N.V. (MRUS)
Monalizumab	ASTRAZENECA PLC (AZN)
osimertinib	ASTRAZENECA PLC (AZN)
Osimertinib 80mg/40mg	ASTRAZENECA PLC (AZN)
Pemetrexed	ASTRAZENECA PLC (AZN)
SKB571 for injection	Merus N.V. (MRUS)

Compare drugs

Alimta® vs Aybintio (SB8)Alimta® vs cosela Alimta® vs cypath lung

Frequently asked questions

How many drugs are in development for Lung Cancer?

BioSniper tracks 469 drugs in development for Lung Cancer across 145 companies.

How many clinical trials target Lung Cancer?

There are 81 clinical trials targeting Lung Cancer tracked by BioSniper.

What is the prevalence of Lung Cancer?

The estimated prevalence of Lung Cancer is approximately 75.0 per 100,000 population.

Deep-dive into Lung Cancer

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis